Who to call at Pulse Biosciences, Inc., and when

Fundz watches for the moments Pulse Biosciences, Inc. starts buying, and tells you who to reach.

An alert the day Pulse Biosciences, Inc. raises, hires an executive or expands, scored against what you sell
The decision-makers there, with verified emails
Who you already know at Pulse Biosciences, Inc., from your own LinkedIn network

See plan options

Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Pulse Biosciences Enters Clinical Partnership with Clayman Thyroid Center

Oct 14, 2026

Contract Type

partnership

HaywardBiotechnologyHealth CareMedicalTherapeutics

Description

On October 14, 2026, Pulse Biosciences, Inc. announced a partnership with the Clayman Thyroid Center to explore the clinical utility of its proprietary nPulse Vybrance Percutaneous Electrode System. This collaboration aims to enhance treatment options within the field of endocrine surgery. The partnership signifies a strategic alignment with a focus on clinical applications of innovative medical technology.

Company Information

Company

Pulse Biosciences, Inc.

Location

3957 POINT EDEN WAY

Hayward, California, United States

About

Pulse Biosciences is the inventor and sole proprietor of Nanosecond Pulsed Field Ablation™ (nsPFA™) technology. We are committed to health innovation that has the potential to improve and extend the lives of patients. Our proprietary Nanosecond Pulsed Field Ablation technology delivers nanosecond pulses of electrical energy to non-thermally clear cells while sparing adjacent non-cellular tissue.